Is Acadia Healthcare (ACHC) overvalued or fairly valued?

MarketChacha shows Acadia Healthcare's valuation in context — a trailing P/E of about 40.4, a forward P/E of about 20.0, a price-to-book of about 1.6 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Acadia Healthcare's revenue?

Acadia Healthcare reported revenue of $3.3B for FY2025, with net profit of $-1.1B, per official filings.

What is the share price of Acadia Healthcare (ACHC)?

Acadia Healthcare last traded at $35.16 (-1.3% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Acadia Healthcare

ACHC · NYSE · Healthcare · United States

$35.16-1.3%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:27 PM

Snapshot

TickerACHC

ExchangeNYSE

SectorHealthcare

IndustryMedical Care Facilities

CountryUnited States

Employees25,000

HeadquartersFranklin, United States

Market cap$3.2B

P/E (TTM)40.4

P/B1.6

Volume695.4K

Websitewww.acadiahealthcare.com

Filings tracked5

About Acadia Healthcare

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Profile as reported by Yahoo Finance.

Who owns it

Insiders1.5%
Institutions98.5%
Public & other0.0%

408 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.12.71%
Wellington Management Group, LLP9.87%
FMR, LLC7.47%
Khrom Capital Management LLC5.65%
Vanguard Portfolio Management LLC5.50%
Deerfield Management Company, L.P4.91%
DME Capital Management, LP4.91%
Morgan Stanley4.88%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

Margin has compressed by about 32.5 points over the period — profitability is trending down.

Net margin trend-0.7% → -33.3%

Margin has compressed by about 32.5 points over the period — profitability is trending down.

Return on equity-56.6%

Latest ROE of -56.6% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $878.5M · EPS 0.48

Est. earnings growth -32.9%

Next fiscal year

Rev $3.6B · EPS 1.76

Est. earnings growth +15.9%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$11.4352-wk range$35.82

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$3.2B

Day change

-1.3%

P/E (TTM)

40.4

Fwd P/E

20.0

P/B

1.6

Beta

0.64

Revenue (FY2025)

$3.3B

Net margin

-33.3%

ROE

-56.6%

Revenue CAGR (2y)

+6.4%

EPS (FY2025)

-12.16

Net profit (FY2025)

$-1.1B

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about ACHC

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$3.3B	$-1.1B	-12.16	-33.3%	-56.6%
FY2024	$3.2B	$255.6M	2.78	8.1%	8.3%
FY2023	$2.9B	$-21.7M	-0.24	-0.7%	-0.8%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$828.8M	$4.1M	0.05	0.5%
2025Q4	—	$-1.2B	—	—
2025Q3	$851.6M	$36.2M	0.40	4.3%
2025Q2	$869.2M	$30.1M	0.33	3.5%
2025Q1	$770.5M	$8.4M	0.09	1.1%
2024Q4	—	$32.6M	—	—
2024Q3	$815.6M	$68.1M	0.74	8.4%
2024Q2	$796.0M	$78.5M	0.85	9.9%
2024Q1	$768.1M	$76.4M	0.83	9.9%
2023Q4	—	$57.7M	—	—
2023Q3	$750.3M	$-217.7M	-2.39	-29.0%
2023Q2	$731.3M	$72.3M	0.79	9.9%
2023Q1	$704.3M	$66.0M	0.72	9.4%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Other events
SEC5/18/2026material
8-K — Shareholder vote results, Exhibits
SEC5/6/2026material
10-Q filing
SEC4/30/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC4/29/2026material
8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC4/23/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.